Predictive factors of rebleeding and mortality following endoscopic hemostasis in bleeding peptic ulcers

Hepato-Gastroenterology

Volumn 60, Issue 122, 2013, Pages 112-117

  Bratanic, Andre ^a   Puljiz, Zeljko ^a   Ljubicic, Neven ^b   Caric, Tea ^a   Jelicic, Ivo ^a   Puljiz, Mario ^b   Perko, Zdravko ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Bleeding; Mortality; Peptic ulcer; Prediction; Rebleeding

Indexed keywords

ADRENALIN; PROTON PUMP INHIBITOR;

ANEMIA; ARTICLE; CLIP; ENDOSCOPIC THERAPY; ENDOSCOPY; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; HYPOTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MORTALITY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; SHOCK;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOSTASIS, ENDOSCOPIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RECURRENCE;

EID: 84877700592     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11838     Document Type: Article

References (23)

1. Rockall TA, Logan RFA, Devlin HB, Northfield TC: Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ 1995; 311:222-226.
2. Van Leerdam ME, Vreeburg EM, Rauws EA, et al.: Acute upper GI bleeding:did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98:1494-1499. (Pubitemid 36875338)
3. Gralnek IM, Jensen DM, Kovacs TP, et al.: An economic analysis of patients with active arterial peptic ulcer haemorrhage treated with endoscopic heater probe, injection sclerosis, or surgery in a prospective, randomized trial. Gastrointest Endosc 1997; 46:105-112. (Pubitemid 27424365)
4. Barkun A, Bardou M, Marshall JK, Non-variceal Upper GI Bleeding Consensus Conference Group: Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139:843-857.
5. Leontiadis GI, Sharma VK, Howden CW: Proton pump inihibtor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2010; 12:CD002094.
6. Sung JJ, Barkun A, Kuipers EJ, et al.: Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150:455-464.
7. Barkun A, Sabbah S, Enns R, et al.: Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004; 99:1247-1249.
8. Oxner RB, Simmonds NJ, Gertner DJ, Nightingale JM, Burnham WR: Controlled trial of endoscopic injection treatment for bleeding from peptic ulcers with visible vessels. Lancet. 1992; 339:966-968.
9. Cook DJ, Guyatt GH, Salena BJ, Laine LA: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102:139-148.
10. Hu ML, Wu KL, Chiu KW, et al.: Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers. World J Gastroenterol 2010; 16:5490-5495.
11. Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M: Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 2009; 69:786-799.
12. Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L: Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostasic therapy for bleeding peptic ulcers. Am J Gastroenterol 2008; 103:2625-2632.
13. Chung IK, Kim EJ, Lee MS, et al.: Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy 2001; 33:969-975. (Pubitemid 33034735)
14. Liu NJ, Lee CS, Tang JH, et al.: Outcomes of bleeding peptic ulcers: a prospective study. J Gastroenterol Hepatol 2008; 23:340-347.
15. Fein F, Weber A, Koch S, et al.: The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials. Eur J Gastroenterol Hepatol 2010; 22:361-367.
16. Godil A, DeGuzman L, Schilling RC 3rd, Khan SA, Chen YK: Recent non-steroidal anti-inflammatory drug use increases the risk of early recurrence of bleeding in patients presenting with bleeding ulcer. Gastrointest Endosc 2000; 51:146-151. (Pubitemid 30094505)
17. Schilling D, Demel A, Nüsse T, Weidmann E, Riemann JF: Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy 2003; 35:393-396. (Pubitemid 36559485)
18. Branicki FJ, Coleman SY, Fok PJ, et al.: Bleeding peptic ulcer: A prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990;14:262-270.
19. Park KG, Steele RJ, Mollison J, Crofts TJ: Prediction of recurrent bleeding after endoscopic haemostasis in non-variceal upper gastrointestinal haemorrhage. Br J Surg 1994; 81:1465-1468. (Pubitemid 24305991)
20. Lau JYW, Sung JJY, Lam Y, et al.: Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999; 340:751-756. (Pubitemid 29114293)
21. Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY: Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007; 56:1364-1373.
22. Chiu PW, Ng EK, Cheung FK, et al.: Predicting mortality in patients with bleeding peptic ulcers after theraoeutic endoscopy. Clin Gastroenterol Hepatol 2009; 7:311-316.
23. Cheng CL, Lin CH, Kuo CJ, et al.: Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig Dis Sci 2010; 55:2577-2583.